There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

Javad Mohammadi stated that this vaccine will be able to cover all types of cancers and it will be unveiled in the summer of 2025. Mohammadi mentioned that knowledge-based companies based at the ...

"This strong and durable activation in T cells was encouraging and indicates that we're able to generate a long-lasting, anti-cancer immune response with the vaccine," Braun explained. The ...

In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.